Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
Will General Catalyst’s plans for health system acquisition come to fruition in 2024? Will GenAI live up to its hype as healthcare’s ultimate complexity liberator?
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.
Liz Beatty is co-founder and chief strategy officer at Inato, a clinical trials platform which flips the traditional model and allows community sites to participate in the trials that are best aligned with their interests and that of their patients.
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they're interested.